Venus Medtech (Hangzhou) Inc. (2500)의 가격은 얼마입니까?

Venus Medtech (Hangzhou) Inc. (2500)의 가격은 $0.13048475입니다.

Venus Medtech (Hangzhou) Inc. (2500)의 시가 총액은 무엇입니까?

Venus Medtech (Hangzhou) Inc. (2500)의 시가 총액은 $57.55M입니다.

Venus Medtech (Hangzhou) Inc. (2500) 액면분할

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.

연도	주식 분할	배수	누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

주식 분할

배수

누적 배수

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	주식 분할 횟수	누적 배수	국가
STERIS plc STE.US	2	x4	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0	-	CN
Ypsomed Holding AG YPSN.SW	0	-	CH
Medacta Group S.A. MOVE.SW	0	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0	-	CN

회사

주식 분할 횟수

누적 배수

국가